Rankings
▼
Calendar
ANIK FY 2021 Earnings — Anika Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
ANIK
Anika Therapeutics, Inc.
$213M
FY 2021 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$148M
+13.3% YoY
Gross Profit
$83M
56.1% margin
Operating Income
$3M
1.8% margin
Net Income
$4M
2.8% margin
EPS (Diluted)
$0.28
Cash Flow
Operating Cash Flow
$8M
Free Cash Flow
$3M
Stock-Based Comp.
$11M
Balance Sheet
Total Assets
$348M
Total Liabilities
$60M
Stockholders' Equity
$287M
Cash & Equivalents
$94M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$148M
$130M
+13.3%
Gross Profit
$83M
$69M
+20.2%
Operating Income
$3M
-$28M
+109.2%
Net Income
$4M
-$24M
+117.2%
← Q4 2020
All Quarters
Q1 2021 →